Skip to main content
OpenTrials

Clinical trial condition

Stage III Mantle Cell Lymphoma

Explore clinical trials studying Stage III Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

44 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage III Mantle Cell Lymphoma trial results

Completed

Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT02242097

Conditions
Contiguous Stage II Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Northwestern University- Lake Forest Hospital Lake Forest, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913

Conditions
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details
Completed

Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT01527149

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

NCT00040846

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +164 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details

Related conditions